Send feedback

NPHS2 p.Ser96=

c.288C>T · rs3738423 · VCV260426

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 10 submitters
gnomAD v4.1
Common
common (popmax 9.05%, nfe) — too common for a highly-penetrant pathogenic allele
Conditions
2
nephrotic syndrome, type 2

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
PangolinΔ0.21loss · gain 0.00 · SpliceAI below 0.2 · independent
Constraint at this position
ConservationphyloP -0.32GERP -2.8
Overall
CADD3.262PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 9.05% European (non-Finnish) · 106,612/1,178,576 alleles
Filtering AF 9% ClinGen BA1/BS1 input FAF95, joint · FAF99 8.98%
Overall 8.42% 135,724/1,612,474 alleles · common exomes 122,921/1,460,280 · genomes 12,803/152,194 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 13.1% 8
Amishnot grpmax-eligible 11.2% 9
European (non-Finnish)grpmax 9.05% 11
African / African-American 8.65% 12
Remaining individualsnot grpmax-eligible 8.24% 12
East Asian 7% 14
Ashkenazi Jewishnot grpmax-eligible 6.56% 15
Admixed American 4.31% 23
Middle Eastern 1.4% 71
South Asian 1.37% 73

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
NPHS2
Protein
p.Ser96=
Coding
c.288C>T
MANE Select
NM_014625
dbSNP
rs3738423
Type
single nucleotide variant
Location
chr1:179564780 (GRCh38)
Gene constraint
LOEUF 1.319 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 75.00
Residue 96
a UniProt-annotated variant site (in nphs2)
Full NPHS2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

nephrotic syndrome, type 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: steroid-resistant nephrotic syndrome

For Hereditary steroid-resistant nephrotic syndrome (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive
Onset
Adolescent, Adult, Antenatal, Childhood, Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nphs2-p-ser96 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown